Skip to main content
Sanofi logo

Sanofi — Investor Relations & Filings

Ticker · SAN ISIN · FR0000120578 LEI · 549300E9PC51EN656011 PA Manufacturing
Filings indexed 4,405 across all filing types
Latest filing 2025-08-06 M&A Activity
Country FR France
Listing PA SAN

Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.

Recent filings

Filing Released Lang Actions
Communiqué de presse : Sanofi finalise l’acquisition de Vigil Neuroscience, Inc.
M&A Activity Classification · 100% confidence The document is a press release announcing the finalization of an acquisition of Vigil Neuroscience, Inc. by Sanofi. It details the financial terms of the transaction, including the price per share and the inclusion of a contingent value right (CVR). This falls squarely under M&A activity, which is categorized as 'TAR'.
2025-08-06 French
Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
M&A Activity Classification · 100% confidence The document is a press release announcing the completion of an acquisition of Vigil Neuroscience, Inc. by Sanofi. It details the terms of the transaction, including the purchase price per share and the inclusion of a contingent value right (CVR). This falls squarely under the definition of M&A activity (mergers, acquisitions, and takeovers).
2025-08-06 English
Sanofi : Déclaration des transactions sur actions propres
Transaction in Own Shares Classification · 100% confidence The document is titled 'Déclaration des transactions sur actions propres' (Declaration of transactions on own shares) and provides a detailed table of share buyback transactions conducted by Sanofi between July 28, 2025, and August 1, 2025. This matches the definition for 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2025-08-04 English
Sanofi: Disclosure of trading in own shares
Transaction in Own Shares Classification · 100% confidence The document is a formal disclosure by Sanofi regarding the purchase of its own shares (share buyback) over a specific period (28 July 2025 to 01 August 2025). It includes detailed tables of daily transaction volumes, weighted average prices, and individual trade logs. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-08-04 English
Press release: Online availability of Sanofi’s half-year financial report for 2025
Report Publication Announcement Classification · 100% confidence The document is a short press release (under 5,000 characters) that explicitly announces the online availability and filing of the company's half-year financial report. It directs readers to the company website to access the actual report. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2025-07-31 English
Communiqué de presse : Mise en ligne du rapport financier semestriel 2025 de Sanofi
Report Publication Announcement Classification · 100% confidence The document is a short press release (2609 characters) that announces the availability and filing of the company's semi-annual financial report with the AMF. It does not contain the financial report itself, but rather directs readers to the company's website to access it. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2025-07-31 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.